Does OFATUMUMAB Cause Product dose omission in error? 86 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 86 reports of Product dose omission in error have been filed in association with OFATUMUMAB (ARZERRA). This represents 0.3% of all adverse event reports for OFATUMUMAB.
86
Reports of Product dose omission in error with OFATUMUMAB
0.3%
of all OFATUMUMAB reports
0
Deaths
10
Hospitalizations
How Dangerous Is Product dose omission in error From OFATUMUMAB?
Of the 86 reports, 10 (11.6%) required hospitalization, and 1 (1.2%) were considered life-threatening.
Is Product dose omission in error Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OFATUMUMAB. However, 86 reports have been filed with the FAERS database.
What Other Side Effects Does OFATUMUMAB Cause?
Fatigue (5,202)
Headache (4,430)
Pain (3,382)
Chills (3,372)
Pyrexia (3,370)
Influenza like illness (2,727)
Nausea (1,688)
Multiple sclerosis relapse (1,525)
Covid-19 (1,435)
Asthenia (1,393)
What Other Drugs Cause Product dose omission in error?
DUPILUMAB (7,586)
TOFACITINIB (2,461)
LENALIDOMIDE (618)
PALBOCICLIB (592)
DIROXIMEL (481)
ABALOPARATIDE (457)
NIRAPARIB (428)
RUXOLITINIB (425)
TERIFLUNOMIDE (371)
DIMETHYL (308)
Which OFATUMUMAB Alternatives Have Lower Product dose omission in error Risk?
OFATUMUMAB vs OFLOXACIN
OFATUMUMAB vs OLANZAPINE
OFATUMUMAB vs OLANZAPINE\SAMIDORPHAN L-MALATE
OFATUMUMAB vs OLAPARIB
OFATUMUMAB vs OLARATUMAB